| Factor Information | |
|---|---|
| Data ID | 1305 |
| Factor | extracorporeal membrane oxygenation(ECMO) at time of diagnosis |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | in-hospital mortality |
| p Value | <0.01 |
| Conclusion | A majority of patients with acquired or congenital heart disease who suffer stroke present while hospitalized and without focal neurologic findings. In-hospital mortality is associated with inotropes, cardiac procedures, lack of seizure, and parenchymal hemorrhage. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 515 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | SV/TOF/TGA/PVS/MVA/AVA/other |
| Reference | |
|---|---|
| PMID | 27509364 |
| Year | 2016 |
| Title | Stroke in Acquired and Congenital Heart Disease Patients and Its Relationship to Hospital Mortality and Lasting Neurologic Deficits. |
| Sample | ||
|---|---|---|
| Population | Infants | |
| Source | retrospective review of cardiac, neurologic, and radiologic patient databases. | |
| Region | Boston, United States | |
| Method | Single-center, retrospective | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiac procedures | |
| Group | Hospital Mortality(Treatment) | Hospital Survival(Control) |
| Number | 12(total:28) | 6(total:56) |
| Age | Age at stroke: 2.3 (0.5–13.4) months | Age at stroke: 10.3 (0.9–87.9) months |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 12(43%) | 8 (14%) |
